Ross Tsuyuki

 rtt03402.jpeg

Adjunct Professor, Department of Pharmacology (past chair, Pharmacology)
Professor of Medicine (Cardiology)
Director, EPICORE Centre

Contact Information:

Office: EPICORE Centre, 362 J1 Heritage Medical Research Centre
Lab: EPICORE Centre, 362 Heritage Medical Research Centre
Email: rtsuyuki@ualberta.ca

Education:

BSc(Pharm): Faculty of Pharmaceutical Sciences, University of British Columbia
Hospital Residency, St. Paul’s Hospital, Vancouver and University of British Columbia
PharmD: State University of New York at Buffalo
Postdoctoral Fellowship, Cardiovascular Clinical Trials, Division of Cardiology, McMaster University
MSc (Health Research Methods), McMaster University

Teaching

PMCOL200: Clinical trials
MED515: Pharmacotherapy of Heart Failure

Research Interests / Laboratory Techniques

Clinical trials, Health Services Research, Cardiovascular Medicine

 

Select Recent Publications

  1. Beahm NP*, Smyth DJ, Tsuyuki RT. Outcomes of Urinary Tract Infection Management by Pharmacists (RxOUTMAP): A study of pharmacist prescribing and care in patients with uncomplicated urinary tract infections in the community.  Can Pharm J 2018;151(5):305-314. DOI: 10.1177/1715163518781175
  2. Tsuyuki RT, Lockwood EE*, Shibata MC, Simpson SH, Tweden KL, Gutierrez R, Reddy MC, Rowe BH, Villa-Roel C, Fradette M. A Randomized Trial of Video-based Education in Patients With Heart Failure: The Congestive Heart Failure Outreach Program of Education (COPE). CJC Open 2019;1(2):62-68.
  3. Rabi D, et al. Hypertension Canada’s 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children. Can J Cardiol 2020;36:596-624. https://doi.org/10.1016/j.cjca.2020.02.086
  4. Tsuyuki RT, Midodzi W*, Villa-Roel C, Marciniuk D, Mayers I, Vethanayagam D, Chan MCY, Rowe BH. Diagnostic Practices for Patients with Shortness of Breath and Presumed Obstructive Airways Disorders: a cross-sectional analysis. CMAJ Open 2020;8(3):E605-E612. DOI:10.9778/cmajo.20190168. Published online September 25, 2020.
  5. Tsuyuki RT, Arora V, Barnes M, Beazely MA, Boivin M, Christofides A, Patel H, Laroche J, Sihota A, So R*. Canadian national consensus guidelines for naloxone prescribing by pharmacists. Can Pharm J 2020;153(6):347-351. DOI: 10.1177/1715163520949973. First published August 26, 2020. French translation: Lignes directrices canadiennes de consensus national pour la prescription de naloxone par les pharmaciens. Can Pharm J 2020;153(6):1-5.
  6. Al Hamarneh YN, Marra C, Gniadecki R, Keeling S, Morgan A, Tsuyuki R. RxIALTA: evaluating the effect of a pharmacist-led intervention on CV risk in patients with chronic inflammatory diseases in a community pharmacy setting: a prospective pre–post intervention study. BMJ Open 2021;11:e043612. doi:10.1136/bmjopen-2020-043612. First published March 24, 2021.
  7. Smyth P, Watson KE*, Al Hamarneh YN, Tsuyuki RT. The effect of nurse practitioner (NP-led) care on health-related quality of life in people with multiple sclerosis – a randomized trial. BMC Neurology 2022;22:275. https://doi.org/10.1186/s12883-022-02809-9
  8. Servito M*, Khani-Hanjani A, Smith K-M, Tsuyuki RT, Mullen JC. Topical Vancomycin and Risk of Sternal Wound Infections: A Double-Blind Randomized Controlled Trial. Ann Thoracic Surgery 2022;114:1555-61. https://doi.org/10.1016/j.athoracsur.2021.11.012
  9. Sharman J, Ordunez P, Brady T, Parati G, Stergiou G, Whelton P, Padwal R, Olsen M, Delles C, Schutte A, Tomaszewski M, Lackland D, Khan N, McManus R, Tsuyuki R, Zhang X-H, Murphy L, Moran A, Schlaich M, Campbell N. The Urgency to Regulate Validation of Automated Blood Pressure Measuring Devices: A Policy Statement and Call to Action from the World Hypertension League. J Hum Hypertension, 2023. https://doi.org/10.1038/s41371-022-00747-0.
  10. Watson KE*, Dhaliwal K*, Robertshaw S, Verdin, Benterud ER, Lamont N, Drall KM, McBrien K, Donald M, Tsuyuki RT, Campbell DJT, Pannu N, James MT. Consensus Recommendations for Sick Day Medication Guidance for People With Diabetes, Kidney, or Cardiovascular Disease: A Modified Delphi Process. Am J Kid Dis 2023; 81(5): 564-574. doi: 10.1053/ j.ajkd.2022.10.012.
  11. Campbell DJT, Mitchell C, Hemmelgarn BR, Tonelli M, Faris P, Zhang J, Tsuyuki RT, Fletcher J, Au F, Klarenbach S, Exner DV, Manns BJ, for the Interdisciplinary Chronic Disease Collaboration. Eliminating Medication Copayments for Low-income Older Adults at High Cardiovascular Risk: a Randomized Controlled Trial. Circulation 2023;147:1505-1514. DOI: 10.1161/CIRCULATIONAHA.123.064188
  12. Campbell DJT, Tonelli M, Hemmelgarn BR, Faris P, Zhang J, Au F, Tsuyuki RT, Mitchell C, Pannu R, Campbell T, Ivers N, Fletcher J, Exner DV, Manns BJ, for the Interdisciplinary Chronic Disease Collaboration. Self-management Support Using Advertising Principles for Older Low Income Adults at High Cardiovascular Risk: a Randomized Controlled Trial. Circulation 2023;147:1492-1504. DOI: 10.1161/CIRCULATIONAHA.123.064189
  13. Dixon DL, Johnston K, Patterson J, Marra C, Tsuyuki RT. Cost-effectiveness of Pharmacist-Prescribing for Managing Hypertension in the United States. JAMA Network Open 2023; 6(11)e2341408. DOI:10.1001/jamanetworkopen.2023.41408
  14. Chan JCH*, Vandermeer I*, Picone DS, Tsuyuki RT. Validity of Home Blood Pressure Devices Sold in Canada. Can J Cardiol Open 2023: DOI: https://doi.org/10.1016/j.cjco.2023.10.001.
  1. Lee TA, King M*, Young SW, Tsuyuki RT. Community pharmacy-based blood pressure screening in Newfoundland and Labrador, Canada for World Hypertension Day 2022: A cross-sectional study. Can J Cardiol Open 2024;6:728-734. DOI: 10.1016/j.cjco.2023.12.012
  2. Watson KE*, Chan JCH*, Al Hamarneh YN, Tsuyuki RT. Enhancing hypertension detection and control through a hypertension certification program for pharmacists: A cluster randomized trial (The RxPATH Study). Can Pharm J (Ott) 2024;157(4):190-199. DOI: 10.1177/17151635241254089.
  3. Sandhu RK, Fradette M, Lin M, Youngson E, Lau D, Bungard TJ, Tsuyuki RT, Dolovich L, Healey JS, McAlister FA. Stroke Risk Reduction in Atrial Fibrillation Through Pharmacist Prescribing. A Randomized Clinical Trial. JAMA Network Open 2024;7(7);e2421993. DOI: 10.1001/jamanetworkopen.2024.21993